Premium
Dissecting Ascaris glycosphingolipids for immunomodulatory moieties – the use of synthetic structural glycosphingolipid analogues
Author(s) -
KEAN D. E.,
OHTSUKA I.,
SATO K.,
HADA N.,
TAKEDA T.,
LOCHNIT G.,
GEYER R.,
HARNETT M. M.,
HARNETT W.
Publication year - 2006
Publication title -
parasite immunology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.795
H-Index - 75
eISSN - 1365-3024
pISSN - 0141-9838
DOI - 10.1111/j.1365-3024.2005.00801.x
Subject(s) - glycosphingolipid , phosphorylcholine , biology , ascaris suum , lactosylceramide , ceramide , glycolipid , moiety , biochemistry , cytokine , microbiology and biotechnology , chemistry , immunology , stereochemistry , apoptosis , helminths
SUMMARY We have previously shown glycosphingolipids of Ascaris suum to have phosphorylcholine (PC) and non‐PC immunomodulatory moieties. In the present study we further investigated the nature of the immunomodulatory moieties by employing three synthetic glycosphingolipids each possessing features of the original molecule to examine effects on macrophage and dendritic cell (DC) cytokine production and surface co‐stimulatory molecule expression. Compound 2, which lacked PC but contained ceramide, had no effect on either macrophages or DCs. Surprisingly however, Compound 1, which contained PC and hence arguably most resembled the native material, had, with the exception of a small increase in surface antigen expression, no immunomodulatory properties. Conversely, Compound 3, which contained PC but was otherwise least like the native molecule, demonstrated a number of effects on both macrophages and DCs, including induction of Th‐1/pro‐inflammatory cytokines, inhibition of such cytokines induced by IFN‐γ/LPS and increased expression of co‐stimulatory molecules. Taken together these results indicate: (i) that although PC is an immunomodulatory component of the native molecule other structural feature are necessary to allow it to act; (ii) that carbohydrate rather than ceramide is likely to represent a non‐PC immunomodulatory moiety; and (iii) that synthetic PC‐containing molecules have the potential to act as immunomodulatory drugs.